Anxiety and Related Sleep Disorders - Germany

Revenue in the Anxiety and Related Sleep Disorders market is projected to reach US$197.00m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 1.01%, resulting in a market volume of US$207.20m by 2029.
In global comparison, most revenue will be generated United States (US$3.21bn in 2024).
In relation to total population figures, per person revenues of US$29.59 are generated in 2024.

The Anxiety and Related Sleep Disorders market covers sales of three drug classes: anxiolytics, hypnotics, and sedatives. These classes contain different types of drugs, such as benzodiazepines, anticonvulsants, and antihistamines, that reduce anxiety and insomnia symptoms caused by anxiety. These medications mainly fall into the category of prescription drugs.

Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.

Company examples: Pfizer, Bristol-Myers Squibb, GlaxoSmithKline PLC, Johnson & Johnson, and Merck & Co.

Pharmaceutical sales and consumption of anxiolytics
Pharmaceutical sales and consumption hypnotics and sedatives

Non-mental health related sleep disorders
Any other anxiety medications
Psychotherapy

The Anxiety and Related Sleep Disorders market in Germany is experiencing significant growth due to a combination of customer preferences, market trends, local special circumstances, and underlying macroeconomic factors.

Customer preferences: Customers in Germany are increasingly seeking solutions for anxiety and related sleep disorders. This can be attributed to the high-stress levels and demanding lifestyles that many individuals in the country face. As a result, there is a growing demand for products and services that can help alleviate anxiety and improve sleep quality. Customers are looking for effective and safe solutions that can be easily integrated into their daily routines.

Trends in the market: One of the key trends in the Anxiety and Related Sleep Disorders market in Germany is the increasing adoption of natural and holistic approaches. Customers are becoming more conscious of the potential side effects of pharmaceutical drugs and are seeking alternative options. This has led to a rise in the popularity of natural remedies, such as herbal supplements, aromatherapy, and meditation. Additionally, there is a growing interest in non-invasive therapies, such as cognitive behavioral therapy and mindfulness-based stress reduction.

Local special circumstances: Germany has a strong healthcare system and a well-developed pharmaceutical industry. This provides a favorable environment for the growth of the Anxiety and Related Sleep Disorders market. The country also has a high level of awareness and acceptance of mental health issues, which contributes to the demand for solutions in this market. Furthermore, the aging population in Germany is driving the need for effective treatments for sleep disorders, as these conditions are more prevalent among older individuals.

Underlying macroeconomic factors: The German economy has been stable in recent years, with low unemployment rates and increasing disposable incomes. This has allowed individuals to prioritize their health and well-being, leading to a greater willingness to invest in products and services that can improve their quality of life. Additionally, the COVID-19 pandemic has further highlighted the importance of mental health, as many individuals have experienced increased stress and anxiety. This has created a greater demand for solutions in the Anxiety and Related Sleep Disorders market.In conclusion, the Anxiety and Related Sleep Disorders market in Germany is experiencing growth due to customer preferences for effective and safe solutions, the trend towards natural and holistic approaches, the local special circumstances of a strong healthcare system and an aging population, and the underlying macroeconomic factors of a stable economy and increased awareness of mental health. The market is expected to continue expanding as individuals prioritize their well-being and seek solutions for anxiety and sleep disorders.

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Despite what some may think, mental health problems are common in the United States and around the world. Mental health issues, much like other health issues, can be mild, but can also be life altering, affecting the emotional, social, and psychological well-being of the person. Common types of mental illness include mood disorders, anxiety disorders, eating disorders, and personality disorders. Although symptoms of mental illness differ depending on the type of illness and seriousness of the problem, common symptoms of mental health issues include changes in sleeping and eating habits, social withdrawal, feelings of hopelessness, anger, and prolonged sadness, suicidal thoughts, and substance abuse. In 2022, it was estimated that around 36 percent of those in the U.S. aged 18 to 25 years and 29 percent of those aged 26 to 49 years suffered from some form of mental illness in the past year.